Scientific Advisory Board (SAB)

Hovedformålet til NCMM Scientific Advisory Board (SAB) er å gi faglig og strategiske råd, så vel som å måle senterets prestasjoner internasjonalt.

Medlemmer av Scientific Advisory Board

SAB består av seks internasjonalt anerkjente forskere:

  • Prof. Richard Treisman, Director of CRUK London Research Institute, London, UK and Research Director, the Francis Crick Institute, London, UK (Chair of SAB)
  • Dr. Alvis Brazma, EMBL Senior Scientist & Senior Team Leader, EMBL-EBI Hinxton, Cambridge, UK

  • Prof. Margaret Frame, Science Director and Chair of Cancer Biology, Edinburgh Cancer Research Centre, Edinburgh, UK

  • Prof. Olli Kallioniemi, Director SciLifeLab, Stockholm, Sweden

  • Dr. Titia Sixma, Group Leader and Head of Division for Biochemistry at the Netherlands Cancer Institute and Professor of Molecular Medicine at the Erasmus University in Amsterdam, Netherlands

  • Prof. George Vassiliou, Professor of Haematological Medicine, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge

Publisert 9. des. 2016 12:28 - Sist endret 23. okt. 2019 10:29